What an AI prospecting teammate should own
An AI prospecting agent should maintain a focused, evidence-backed set of relevant prospects over time. It should not simply generate a large investor or LP list on demand.
The continuing job is to apply the mandate, find current public evidence, check existing records, explain why each prospect belongs, preserve exclusions, and return the changes that need review. That makes prospecting a responsibility with an owner instead of a recurring scramble across search results and spreadsheets.
This is one of six recurring roles in the broader AI teammates for private capital model.
Meet your prospecting teammate
| Responsibility | Maintain a qualified prospect set for a defined fundraising or sourcing mandate. |
| Working style | Selective, source-linked, duplicate-aware, and willing to exclude weak fits. |
| Needs from you | The mandate, must-have criteria, exclusions, geography, relevant dates, and approval rules. |
| Brings back | New candidates, updated evidence, duplicate matches, exclusions, and the reason each record changed. |
| Reports back | In its ongoing conversation and the reviewed prospecting workflow, before records or outreach advance. |
The best result is often a smaller list. A prospect set becomes valuable when another person can understand why each name is present, which fact is current, and what should happen next.
A prospect list is not a prospecting system
A one-time list starts decaying as soon as it is assembled. People change roles. Funds change strategy. An allocator's current program may not match an older commitment. A company already in the CRM may have an active relationship under a different name.
A prospecting teammate manages these recurring states:
| State | Meaning | Review action |
|---|---|---|
| New | Current evidence supports a possible fit and no matching record was found | Review the fit and source before adding |
| Updated | A material role, thesis, geography, or program detail changed | Decide whether the existing priority still holds |
| Already in CRM | The person or organization appears to match an existing record | Continue the relationship instead of creating a duplicate |
| Monitor | Relevant, but timing or evidence is insufficient | Set a reason to revisit, not a generic reminder |
| Exclude | A stated criterion, conflict, prior decision, or suppression rule disqualifies the prospect | Preserve the reason so the name does not reappear |
| Unverified | The available evidence cannot support the proposed fit | Research further or leave out |
That state model keeps research from becoming an endless source of new rows.
Start with a mandate the teammate can apply
"Find LPs for my fund" is not enough. A useful brief separates facts the teammate can test from judgments that require the GP.
For an emerging manager, the brief might specify:
- fund strategy and target fund size;
- target allocator types;
- relevant geography and any local requirements;
- minimum publicly supported evidence of external-manager activity;
- emerging-manager eligibility or comparable evidence when required;
- exclusions, conflicts, and prior passes;
- evidence freshness standard;
- fields to check before creating a CRM record;
- the human decision required before research becomes outreach.
The SEC explains that private funds pool capital from investors and are managed by advisers, with fund and adviser structures subject to different legal frameworks. Its private-funds overview is useful background, but it does not tell a GP which allocator is likely to invest. Prospect fit still needs mandate-specific evidence.
For an adviser or reporting entity in the United States, Investment Adviser Public Disclosure can help verify certain filed details. A registration or filing is not evidence that the organization is accepting proposals, fits a particular fund, or is prepared to allocate.
Keep discovery, qualification, and access separate
These are three different questions:
- Does the prospect exist and appear relevant? Use current public research, a licensed source the organization is entitled to use, or an authorized list.
- Does the prospect meet the mandate? Compare the evidence with the fund's criteria and document uncertainties.
- Is there a credible way to approach them? Inspect the CRM and authorized relationship evidence after qualification.
Finta does not maintain a proprietary, marketwide investor database like PitchBook or Crunchbase. A team can combine Aurora web research, compatible licensed sources, external research through Finta MCP, and its own lists. Selected prospects can then be deduplicated and organized in Finta CRM.
The separation matters. A database profile may support discovery. A relationship path may support access. Neither proves investment fit, current appetite, permission to use a connection, or likely acceptance.
Use a qualification record that can survive review
For each proposed prospect, save enough evidence to reproduce the decision.
| Field | Question it answers |
|---|---|
| Entity and domain | Which organization is this, and have aliases been reconciled? |
| Relevant program or mandate | What official current evidence supports possible fit? |
| Evidence date | When was the source published or last checked? |
| Fit explanation | Which stated criteria appear satisfied? |
| Missing evidence | What important requirement remains unknown? |
| Existing record | Is there already a CRM organization, contact, pass, or active relationship? |
| Relationship state | Is there authorized evidence of a possible path, and who owns it? |
| Inclusion decision | New, updated, monitor, exclude, or unverified? |
| Next human action | Review, research, assign, approach directly, ask a relationship owner, or stop? |
Do not let multiple employees, vehicles, or aliases inflate the prospect count. Organize the investment organization first, then add people and roles as relationship records when they are relevant.
Illustrative example: maintaining an LP shortlist
The following example is synthetic.
Meridian Ventures is raising Fund III and wants a reviewable shortlist of institutional LPs, family offices, and funds of funds that may consider its strategy. The GP gives the prospecting teammate this responsibility:
Maintain a shortlist of organizations with current public evidence relevant to our strategy. Check the CRM before proposing anything new. Preserve exclusions and old passes. For each candidate, show the source date, why it may fit, what remains unknown, and the next review decision. Do not infer appetite from a generic profile or prepare outreach until I approve the prospect.
On the next run, the teammate reports:
- Two new: Both have current official evidence of investing with external managers and a documented route for proposals.
- One updated: A program's geography changed, so the existing record needs review.
- Three already in CRM: One has a live conversation, one was previously passed for timing, and one appears under an earlier organization name.
- Four excluded: Two lack mandate-specific evidence, one is a wealth adviser rather than an allocator, and one is currently outside the strategy's geography.
- One unverified: A conference biography suggests relevance, but no current organizational source supports it.
The GP reviews the two new candidates and assigns one for deeper research. Nothing about that decision implies an allocation, introduction, or response.
Common failure modes
Optimizing for list size
A large output can hide weak sourcing, duplicates, and impossible fits. Measure reviewed additions and useful updates, not names generated.
Treating old activity as a current mandate
One historical fund commitment or portfolio company may justify research. It does not establish present eligibility, check size, or appetite.
Ignoring negative decisions
If exclusions and passes disappear, the same poor-fit prospects return on every run. Preserve the reason and date.
Mixing the person with the institution
A person's location, title, or conference appearance does not automatically define the organization's investment authority or mandate.
Advancing directly to outreach
Research is not send authorization. A selected prospect still needs an owner, appropriate relationship motion, current claims, recipient check, and the required review.
What still needs a person
The GP, founder, or deal lead remains responsible for:
- defining the target and the exclusions;
- deciding whether the evidence is sufficient;
- judging strategic fit and relationship sensitivity;
- choosing direct outreach or a permissioned introduction request;
- approving CRM changes that affect the operating pipeline;
- approving any external message;
- complying with securities, privacy, communication, and professional obligations.
Stop when identity, mandate, source rights, relationship ownership, or communication permission is unclear.
Put a responsible owner behind the shortlist
The investor prospecting workflow shows how public research, licensed sources, external AI through MCP, and user-owned lists can feed a reviewed CRM process. Finta for emerging fund managers applies that separation to LP fundraising and investment sourcing.
With Aurora, the prospecting role can keep the criteria, recurring research, record checks, corrections, and report-backs together. Continue with the AI relationship-mapping teammate after prospects are qualified and the next question becomes how to approach them appropriately.
Explore Aurora to give recurring prospect research a recognizable owner without treating Finta as a proprietary investor database.
Research checked September 27, 2026. This article provides operational education, not investment, legal, tax, compliance, broker-dealer, or placement-agent advice. Verify sources, data rights, eligibility, and communications requirements for your organization.